1. 2137 Percentage of viable tumor Versus radiation treatment effect in surgical specimens is not associated with outcomes in recurrent glioblastoma. (21st November 2018) Authors: Schwab, Robert D.; Bagley, Stephen; Binder, Zev; Lustig, Robert; O'Rourke, Donald; Brem, Steven; Desai, Arati S.; Nasrallah, MacLean Journal: Journal of clinical and translational science Issue: Volume 2(2018)Supplement 1 Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BIOM-18. METHYLATION ANALYSIS TO REVEAL THE CELLULAR ORIGIN OF PROGNOSTIC CIRCULATING CELL-FREE DNA IN GLIOBLASTOMA. (12th November 2021) Authors: Till, Jacob; Abdalla, Aseel; Wang, Zhuoyang; Zhou, Wanding; Nabavizadeh, S Ali; Binder, Zev; Hussain, Jasmin; Black, Taylor; Yee, Stephanie; Desai, Arati; Bagley, Stephen J; Carpenter, Erica Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CSIG-25. EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR DOMAIN MISSENSE MUTATION A289V AS A DRIVER OF GLIOBLASTOMA INVASION AND PROLIFERATION. (5th November 2018) Authors: Binder, Zev; Thorne, Amy; Bakas, Spyridon; Wileyto, E Paul; Akbari, Hamed; Rathore, Saima; Min Ha, Sung; Zhang, Logan; Idbaih, Ahmed; Bagley, Stephen; Morrissette, Jennifer; Nasrallah, MacLean; Ma, Jianhui; Zanca, Ciro; Scott, Andrew; Davatzikos, Christos; Furnari, Frank; O'Rourke, Donald Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTIM-35. A PHASE II STUDY OF GITR AGONIST INCAGN01876 AND PD-1 INHIBITOR RETIFANLIMAB IN COMBINATION WITH STEREOTACTIC RADIOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (14th November 2022) Authors: Bagley, Stephen; Shabason, Jacob; Mathew, Divij; Kothari, Shawn; Oldridge, Derek; Desai, Arati; Lustig, Robert; Kurtz, Goldie; Alonso-Basanta, Michelle; Chen, Kan; Long, Qi; Harsch, Jessica; Salman, Muhammad; Fernandez, Peter; Monsour, Maikel; Prior, Timothy; Maloney, Eileen; MacMurtrie, Eileen; ... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EXTH-37. PAK4 INHIBITION REPROGRAMS VASCULAR MICROENVIRONMENT AND IMPROVES CAR T IMMUNOTHERAPY IN GLIOBLASTOMA. (12th November 2021) Authors: Yang, Fan; Binder, Zev; O'Rourke, Donald M; Fan, Yi Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma. Issue 1 (December 2018) Authors: Gallia, Gary; Zhang, Ming; Ning, Yi; Haffner, Michael; Batista, Denise; Binder, Zev; Bishop, Justin; Hann, Christine; Hruban, Ralph; Ishii, Masaru; Klein, Alison; Reh, Douglas; Rooper, Lisa; Salmasi, Vafi; Tamargo, Rafael; Wang, Qing; Williamson, Tara; Zhao, Tianna; Zou, Ying; Meeker, Alan Journal: Nature communications Issue: Volume 9:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. IMMU-16. CHARACTERISTICS OF EGFRVIII-DIRECTED CART CELL INFUSION PRODUCT ASSOCIATED WITH CLINICAL RESPONSE IN RECURRENT GLIOBLASTOMA. (12th November 2021) Authors: Tang, Oliver; Binder, Zev; Tian, Lifeng; Chang, Wan-Jung; Yoder, Todd; Lacey, Simon; Melenhorst, Jos; O'Rourke, Donald M Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. IMMU-36. HIGH AFFINITY CHIMERIC ANTIGEN RECEPTOR WITH CROSS-REACTIVITY TO CLINICALLY-RELEVANT EGFR MUTATED PROTEINS. (9th November 2020) Authors: Thokala, Radhika; Binder, Zev; Yin, Yibo; Milone, Michael; O'Rourke, Donald M Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IMMU-38. DEEP IMMUNOPROFILING OF HUMAN GLIOBLASTOMA (GBM) REVEALS DIFFERENCES IN THE TUMOR IMMUNE CELL INFILTRATE IN PATIENTS WITH HIGH VS. LOW PLASMA CELL-FREE DNA (CFDNA). (12th November 2021) Authors: Bagley, Stephen J; Alanio, Cecile; Till, Jacob; Abdalla, Aseel; Binder, Zev; Desai, Arati; Brem, Steven; O'Rourke, Donald M; Carpenter, Erica; Wherry, E John Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IMMU-48. RATIONAL DEVELOPMENT AND CHARACTERIZATION OF MULTIVALENT TARGETING TANDEM AND PARALLEL CAR T CELLS FOR GLIOMA. (11th November 2019) Authors: Yin, Yibo; Thokala, Radhika; Zhang, Logan; Kainth, Devneet; Haddad, Leila; Binder, Zev; Lin, Zhiguo; O'Rourke, Donald Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗